Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

EQL Pharma AB (7JK) Stock Price & Analysis

0 Followers

7JK Stock Chart & Stats

€2.31€0.01(1.54%)
At close: 5:30 PM GMT+1
€1.8€2€2.2Jun 15Jul 29
Day’s Range
EUR 2.31 - EUR 2.45
52-Week Range
EUR 1.66 - EUR 6.26
Previous Close
EUR 2.27
Volume
N/A
Average Volume (3M)
0
Market Cap
EUR 69.28M
Enterprise Value
EUR 1.10B
Total Cash (Recent Filing)
N/A
Total Debt (Recent Filing)
EUR 0
Price to Earnings (P/E)
―
Beta
1.02
Next Earnings
Feb 04, 2027 (Est.)
EPS Estimate
0.01
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

EQL Pharma AB News

7JK FAQ

What was EQL Pharma AB’s price range in the past 12 months?
EQL Pharma AB lowest stock price was €1.66 and its highest was €6.26 in the past 12 months.
What is EQL Pharma AB’s market cap?
EQL Pharma AB’s market cap is €69.28M.
When is EQL Pharma AB’s upcoming earnings report date?
EQL Pharma AB’s next earnings report is estimated for Feb 04, 2027 (not yet confirmed), which is in 85 days.
How were EQL Pharma AB’s earnings last quarter?
EQL Pharma AB released its earnings results on Nov 05, 2026. The company reported €0.083 earnings per share for the quarter, beating the consensus estimate of €0.013 by €0.07.
Is EQL Pharma AB overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does EQL Pharma AB pay dividends?
EQL Pharma AB does not currently pay dividends.
What is EQL Pharma AB’s EPS estimate?
EQL Pharma AB’s EPS estimate is 0.01.
How many shares outstanding does EQL Pharma AB have?
EQL Pharma AB has 29,529,610 shares outstanding.
What happened to EQL Pharma AB’s price movement after its last earnings report?
EQL Pharma AB reported an EPS of €0.083 in its last earnings report, beating expectations of €0.013. Following the earnings report the stock price went up 13.3%.
Which hedge fund is a major shareholder of EQL Pharma AB?
Currently, no hedge funds are holding shares in DE:7JK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology